Montu has submitted a formal response to the Productivity Commission's national inquiry into data, digital technology and care delivery, pushing for consistent regulation across the country to support telehealth, AI and prescribing initiatives.
Jodie Thomas, Montu's vice-president of corporate affairs and patient advocacy, said "inconsistent requirements across states" had created unnecessary complexity for patients and providers, ultimately slowing care delivery.
Although digital tools such as telehealth and AI offered clear advantages in cutting costs and broadening access, Montu cautioned that fragmented, state-based regulation had curtailed their effectiveness.
The company called on governments to build nationally aligned frameworks that support responsible innovation and better address patient needs.
Among its specific proposals, Montu pushed for simplified prescribing rules, formal recognition of telehealth as a form of preventative care, clearer guidelines around AI, and scalable education models. The submission also advocated for greater investment in developing a digital health workforce.
Cann Group
Cann Group has received a second funding advance of more than $315,000 from Radium Capital, giving the company early access to its anticipated FY25 R&D tax incentive.
The funds relate to R&D activities conducted during March and April 2025, and follow an earlier advance of almost $849,000 covering activities through the end of February.
The total amount drawn now sits at approximately $1,152,000, with repayment required upon receipt of the FY25 rebate or by 31 October 2025, whichever occurs first.
